1-15 of 15
Jeffrey Schlom
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P034: Tumor-targeted interleukin-12 and Entinostat combination therapy improves cancer survival by reprogramming the tumor immune cell landscape

Kristin C. Hicks, Paul L. Chariou, Yohei Ozawa, Christine M. Minnar, Karin M. Knudson, Thomas J. Meyer, Jing Bian, Margaret Cam, Jeffrey Schlom, Sofia R. Gameiro
Journal: Cancer Immunology Research
Cancer Immunol Res (2022) 10 (1_Supplement): P034.
https://doi.org/10.1158/2326-6074.TUMIMM21-P034
Published: 01 January 2022
View article titled, Abstract P034: Tumor-targeted interleukin-12 and Entinostat combination therapy improves cancer survival by reprogramming the tumor immune cell landscape
Journal Articles

Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable

Kellsye P. Fabian, Anthony S. Malamas, Michelle R. Padget, Kristen Solocinski, Benjamin Wolfson, Rika Fujii, Houssein Abdul Sater, Jeffrey Schlom, James W. Hodge
Journal: Cancer Immunology Research
Cancer Immunol Res (2021) 9 (2): 239–252.
https://doi.org/10.1158/2326-6066.CIR-20-0638
Published: 03 February 2021
View article titled, Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable
Open the PDF for Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable in another window
Includes: Supplementary data
Journal Articles

Abstract B04: Multimodal cancer immunotherapy combining IL-8 inhibition, adenovirus vaccine, IL-15 super agonist, and anti-PD-L1/TGFβRII agent reduces mesenchymalization and enhances anti-tumor efficacy

Lucas Horn, Duane Hamilton, Dean Maeda, John Zebala, John Lee, Shahrooz Rabizadeh, Frank Jones, Patrick Soon-Shiong, Zhen Su, Jeffrey Schlom, Claudia Palena
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (4_Supplement): B04.
https://doi.org/10.1158/2326-6074.TUMIMM18-B04
Published: 01 April 2020
View article titled, Abstract B04: Multimodal cancer immunotherapy combining IL-8 inhibition, adenovirus vaccine, IL-15 super agonist, and anti-PD-L1/TGFβRII agent reduces mesenchymalization and enhances anti-tumor efficacy
Journal Articles

Abstract PR20: A novel combination immunotherapy with a vaccine targeting tumor neoepitopes that mediates immune cascade in murine tumor models

Karin L. Lee, Claudia Palena, John Lee, Kayvan Niazi, Andrew Nguyen, Frank Jones, Shahrooz Rabizadeh, Patrick Soon-Shiong, Jeffrey Schlom, Duane H. Hamilton
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (4_Supplement): PR20.
https://doi.org/10.1158/2326-6074.TUMIMM18-PR20
Published: 01 April 2020
View article titled, Abstract PR20: A novel combination immunotherapy with a vaccine targeting tumor neoepitopes that mediates immune cascade in murine tumor models
Journal Articles

Abstract B43: Simultaneous inhibition of CXCR1/CXCR2, TGF-β, and PD-L1 overcomes immune resistance driven by tumor plasticity

Lucas A. Horn, Jeffrey Riskin, Heidi A. Hempel, Hanne Lind, Kristen Fousek, Duane H. Hamilton, Kristen K. McCampbell, Jeffrey Schlom, Claudia Palena
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (3_Supplement): B43.
https://doi.org/10.1158/2326-6074.TUMIMM19-B43
Published: 02 March 2020
View article titled, Abstract B43: Simultaneous inhibition of CXCR1/CXCR2, TGF-β, and PD-L1 overcomes immune resistance driven by tumor plasticity
Journal Articles

Abstract B29: The importance of epitope spreading in the generation of effective antitumor immunity in mice treated with combination immunotherapy

Karin L. Lee, Claudia Palena, Jeffrey Schlom, Duane H. Hamilton
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (3_Supplement): B29.
https://doi.org/10.1158/2326-6074.TUMIMM19-B29
Published: 02 March 2020
View article titled, Abstract B29: The importance of epitope spreading in the generation of effective antitumor immunity in mice treated with combination immunotherapy
Journal Articles

Abstract A43: Exploiting off-target effects of estrogen receptor-targeting drugs to sensitize breast cancer to immune killing

Benjamin Wolfson, Jeffrey Schlom, James Hodge
Journal: Cancer Immunology Research
Cancer Immunol Res (2020) 8 (3_Supplement): A43.
https://doi.org/10.1158/2326-6074.TUMIMM19-A43
Published: 02 March 2020
View article titled, Abstract A43: Exploiting off-target effects of estrogen receptor-targeting drugs to sensitize breast cancer to immune killing
Journal Articles

Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy

Karin L. Lee, Stephen C. Benz, Kristin C. Hicks, Andrew Nguyen, Sofia R. Gameiro, Claudia Palena, John Z. Sanborn, Zhen Su, Peter Ordentlich, Lars Rohlin, John H. Lee, Shahrooz Rabizadeh, Patrick Soon-Shiong, Kayvan Niazi, Jeffrey Schlom, Duane H. Hamilton
Journal: Cancer Immunology Research
Cancer Immunol Res (2019) 7 (8): 1359–1370.
https://doi.org/10.1158/2326-6066.CIR-18-0620
Published: 01 August 2019
View article titled, Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy
Open the PDF for Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Abstract B82: Identification of tumor neoantigens for combination therapy in murine tumor models

Karin L. Lee, Andrew T. Nguyen, Steven C. Benz, Shahrooz Rabizadeh, James W. Hodge, Claudia Palena, Jeffrey Schlom, Duane H. Hamilton
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (9_Supplement): B82.
https://doi.org/10.1158/2326-6074.TUMIMM17-B82
Published: 01 September 2018
View article titled, Abstract B82: Identification of tumor neoantigens for combination therapy in murine tumor models
Journal Articles

Abstract B64: A high-throughput screen identifies fulvestrant as an enhancer of immune-mediated cytotoxicity of mesenchymal-like lung cancer cells

Duane H. Hamilton, Lesley Mathews-Griner, Jonathan M. Keller, Xin Hu, Noel Southall, Juan Marugan, Justin M. David, Ferrer Ferrer, Jeffrey Schlom, Claudia Palena
Journal: Cancer Immunology Research
Cancer Immunol Res (2017) 5 (3_Supplement): B64.
https://doi.org/10.1158/2326-6074.TUMIMM16-B64
Published: 28 February 2017
View article titled, Abstract B64: A high-throughput screen identifies fulvestrant as an enhancer of immune-mediated cytotoxicity of mesenchymal-like lung cancer cells
Journal Articles

Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy

Benedetto Farsaci, Renee N. Donahue, Italia Grenga, Lauren M. Lepone, Peter S. Kim, Brendan Dempsey, Janet C. Siebert, Nuhad K. Ibrahim, Ravi A. Madan, Christopher R. Heery, James L. Gulley, Jeffrey Schlom
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (9): 755–765.
https://doi.org/10.1158/2326-6066.CIR-16-0037
Published: 01 September 2016
View article titled, Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy
Open the PDF for Analyses of Pretherapy Peripheral Immunoscore and Response to Vaccine Therapy in another window
Includes: Supplementary data
Journal Articles

Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor

Amanda J. Vandeveer, Jonathan K. Fallon, Robert Tighe, Helen Sabzevari, Jeffrey Schlom, John W. Greiner
Journal: Cancer Immunology Research
Cancer Immunol Res (2016) 4 (5): 452–462.
https://doi.org/10.1158/2326-6066.CIR-15-0176
Published: 01 May 2016
View article titled, Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor
Open the PDF for Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti–PD-L1 Immune Checkpoint Inhibitor in another window
Includes: Supplementary data
Journal Articles

Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury

Christopher R. Heery, B. Harpreet Singh, Myrna Rauckhorst, Jennifer L. Marté, Renee N. Donahue, Italia Grenga, Timothy C. Rodell, William Dahut, Philip M. Arlen, Ravi A. Madan, Jeffrey Schlom, James L. Gulley
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (11): 1248–1256.
https://doi.org/10.1158/2326-6066.CIR-15-0119
Published: 04 November 2015
View article titled, Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
Open the PDF for Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury in another window
Includes: Supplementary data
Journal Articles

Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells

Benjamin Boyerinas, Caroline Jochems, Massimo Fantini, Christopher R. Heery, James L. Gulley, Kwong Yok Tsang, Jeffrey Schlom
Journal: Cancer Immunology Research
Cancer Immunol Res (2015) 3 (10): 1148–1157.
https://doi.org/10.1158/2326-6066.CIR-15-0059
Published: 04 October 2015
View article titled, Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells
Open the PDF for Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti–PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells in another window
Includes: Supplementary data
Journal Articles

Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer

James L. Gulley, Ravi A. Madan, Kwong Y. Tsang, Caroline Jochems, Jennifer L. Marté, Benedetto Farsaci, Jo A. Tucker, James W. Hodge, David J. Liewehr, Seth M. Steinberg, Christopher R. Heery, Jeffrey Schlom
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (2): 133–141.
https://doi.org/10.1158/2326-6066.CIR-13-0108
Published: 03 February 2014
View article titled, Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer
Open the PDF for Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer in another window
Includes: Supplementary data